Production (Stage)
Claritas Pharmaceuticals, Inc.
CLAZF
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.29% | 907.14% | 460.00% | -98.98% | 4,354.55% |
| Total Receivables | 0.00% | -5.56% | -47.57% | 24.85% | 26.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.76% | 418.82% | 37.04% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -- |
| Total Current Assets | -1.17% | 842.27% | 21.33% | 48.85% | 364.54% |
|
|
|||||
| Total Current Assets | -1.17% | 842.27% | 21.33% | 48.85% | 364.54% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -26.89% | -2.26% | -25.17% |
| Goodwill | -- | -- | -26.89% | -2.26% | -25.17% |
| Total Other Intangibles | -- | -- | -26.87% | -2.27% | -25.18% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.50% | 60.00% | -16.67% | -98.90% | 10,820.00% |
| Total Assets | -1.17% | 37.56% | -22.36% | -4.04% | -16.84% |
|
|
|||||
| Total Accounts Payable | -11.03% | -56.15% | 4.74% | 5.09% | -39.71% |
| Total Accrued Expenses | 9.58% | -12.56% | -6.44% | 16.40% | 5.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.74% | 33.50% | -56.11% | 11.99% | 8.68% |
| Total Finance Division Other Current Liabilities | 0.00% | 37.05% | 1.30% | 1.37% | 1.36% |
| Total Other Current Liabilities | 0.00% | 37.05% | 1.30% | 1.37% | 1.36% |
| Total Current Liabilities | 0.44% | 15.98% | -6.87% | 5.18% | -5.51% |
|
|
|||||
| Total Current Liabilities | 0.44% | 15.98% | -6.87% | 5.18% | -5.51% |
| Long-Term Debt | -- | -- | -- | -- | 1.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.56% | -46.41% | -28.45% | 2.03% | -47.67% |
| Total Liabilities | -7.74% | 5.80% | -11.24% | 3.69% | -18.91% |
|
|
|||||
| Common Stock & APIC | 0.55% | 7.88% | 1.72% | -0.18% | 0.39% |
| Retained Earnings | 0.31% | -3.39% | -4.18% | -1.20% | -0.77% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 18.79% | 1,469.32% | -88.32% | -33.47% | -7.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.79% | 1,469.32% | -88.32% | -33.47% | -7.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.79% | 1,469.32% | -88.32% | -33.47% | -7.89% |
|
|
|||||